共 50 条
Newly diagnosed and relapsed epithelial ovarian cancer: ESMO Clinical Practice Guideline for diagnosis, treatment and follow-up
被引:115
|作者:
Gonzalez-Martin, A.
[1
,2
,3
,4
,21
]
Harter, P.
[5
]
Leary, A.
[6
]
Lorusso, D.
[7
,8
]
Miller, R. E.
[9
,10
]
Pothuri, B.
[11
]
Ray-Coquard, I.
[12
,13
]
Tan, D. S. P.
[14
,15
,16
,17
]
Bellet, E.
[18
]
Oaknin, A.
[19
]
机构:
[1] Univ Navarra, Canc Ctr Clin, Dept Med Oncol, Madrid, Spain
[2] Univ Navarra, Canc Ctr Clin, Program Solid Tumors Cima, Madrid, Spain
[3] Univ Navarra, Canc Ctr Clin, Dept Med Oncol, Pamplona, Spain
[4] Univ Navarra, Canc Ctr Clin, Program Solid Tumors Cima, Pamplona, Spain
[5] Ev Kliniken Essen Mitte, Dept Gynecol & Gynecol Oncol, Essen, Germany
[6] Univ Paris Saclay, Gustave Roussy Canc Ctr, Dept Med Oncol, INSERM U981, Paris, France
[7] Fdn Policlin Univ Agostino Gemelli IRCSS, Div Gynecol Oncol, Rome, Italy
[8] Univ Cattolica Sacro Cuore, Dept Woman Child & Publ Hlth, Rome, Italy
[9] Univ Coll Hosp, Dept Med Oncol, London, England
[10] St Bartholomews Hosp, Dept Med Oncol, London, England
[11] NYU, Perlmutter Canc Ctr, Dept Obstet & Gynecol, NYU Langone Hlth,Sch Med, New York, NY USA
[12] Ctr Leon Bernard, Dept Med Oncol, Lyon, France
[13] Univ Claude Bernard Lyon I, Lyon, France
[14] Natl Univ Singapore, Yong Loo Lin Sch Med, Dept Med, Singapore, Singapore
[15] Natl Univ Singapore, NUS Ctr Canc Res, Yong Loo Lin Sch Med, Singapore, Singapore
[16] Natl Univ Singapore, Canc Sci Inst, Singapore, Singapore
[17] Natl Univ Singapore Hosp, Natl Univ Canc Inst, Dept Haematol Oncol, Singapore, Singapore
[18] ACTO Alleanza Contro Tumore Ovar Onlus, Milan, Italy
[19] Hosp Univ Vall dHebron, Vall dHebron Inst Oncol VHIO, Gynaecol Canc Programme, Vall dHebron Barcelona Hosp Campus, Barcelona, Spain
[20] UCL, UCL Canc Inst, Dept Oncol, London, England
[21] ESMO Head Off, Via Ginevra 4, CH-6900 Lugano, Switzerland
关键词:
epithelial ovarian cancer;
guideline;
diagnosis;
surgery;
treatment;
follow-up;
PEGYLATED LIPOSOMAL DOXORUBICIN;
PLATINUM-BASED CHEMOTHERAPY;
PHASE-III TRIAL;
CARBOPLATIN PLUS PACLITAXEL;
CLEAR-CELL CARCINOMA;
OPEN-LABEL;
ADJUVANT CHEMOTHERAPY;
FALLOPIAN-TUBE;
NEOADJUVANT CHEMOTHERAPY;
SECONDARY CYTOREDUCTION;
D O I:
10.1016/j.annonc.2023.07.011
中图分类号:
R73 [肿瘤学];
学科分类号:
100214 ;
摘要:
[No abstract available]
引用
收藏
页码:833 / 848
页数:16
相关论文